Cargill Inc. plans to scale back antibiotics use in its U.S. cattle supply, one of the most significant steps yet among beef processors to reduce reliance on drugs used to treat human illnesses.
The Wayzata-based company said it would eliminate one-fifth of such medically important antibiotics from cattle that Cargill processes into ground beef and steaks, affecting an estimated 1.2 million cattle annually.
Read Full Article »